Jonathan B. Zung - Jul 19, 2022 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Chief Development Officer
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Jonathan B. Zung
Stock symbol
EVLO
Transactions as of
Jul 19, 2022
Transactions value $
$0
Form type
4
Date filed
10/14/2022, 04:32 PM
Previous filing
Jan 21, 2022
Next filing
May 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +115K $0.00 115K Jul 19, 2022 Common Stock 115K $2.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as to 50% of the underlying shares on the first anniversary of the date of grant, and as to the remaining 50% of the underlying shares on the second anniversary of the date of grant.